abrdn Life Sciences Investors (HQL)
NYSE: HQLFinanceInvestment ManagersUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HQL stock chart
Technical analysisKey statistics
All statistics- P/E (TTM)
- 2.32
- EPS (TTM)
- $6.64
- Dividend yield
- 12.42% ($1.91)
- Ex-dividend date
- Aug 24, 2026
- 52-week range
- 15.35 – 22.67
- Day range
- 15.36 – 16.06
- Volume / Avg
- 187.61K / 129.21K
- Beta
- —
52-week range
HQL stock today
abrdn Life Sciences Investors (HQL) closed at $15.38 on Nov 20, down 3.81% (-$0.61), versus the S&P 500's 3.70% decline. Shares are 32.2% below their 52-week high of $22.67, set on Aug 19, 2026 and 0.2% above the 52-week low of $15.35, near the bottom of the past year's range. HQL is down 8.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 8.5%.
At 2.3x trailing earnings, abrdn Life Sciences Investors trades below the peer-group median of 7.1x. abrdn Life Sciences Investors pays an annual dividend of $1.91 per share, a 12.42% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About abrdn Life Sciences Investors
Company profileAbrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
- Sector
- Finance
- Industry
- Investment Managers
- Headquarters
- Philadelphia, PA
- IPO year
- 1992
Dividends
Dividend history- Annual dividend
- $1.91
- Dividend yield
- 12.42%
- Last payment
- $0.62
- Ex-dividend date
- Aug 24, 2026
HQL news
All HQL newsabrdn Life Sciences Investors peers
Finance sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ETOEaton Vance Tax-Advantage Global Dividend Opp | 27.28 | -3.88% | $447.07M | vs HQL |
| PCQPIMCO California Municipal Income Fund | 7.84 | +0.13% | $440.49M | vs HQL |
| FTHYFirst Trust High Yield Opportunities 2027 Term Fund | 12.62 | -0.39% | $464.08M | vs HQL |
| NOAHNoah Holdings Limited ADR | 6.11 | -6.29% | $419.43M | vs HQL |
| OXLCOxford Lane Capital Corp. | 4.94 | 0.00% | $484.27M | vs HQL |
| MMUWestern Asset Managed Municipals Fund Inc. | 8.93 | -0.40% | $485.23M | vs HQL |
| IIMInvesco Value Municipal Income Trust | 10.38 | +0.48% | $489.27M | vs HQL |
| FFAFirst Trust Enhanced Equity Income Fund | 20.23 | -2.46% | $404.36M | vs HQL |
Indexes, lists and sector
abrdn Life Sciences Investors stock FAQ
What is abrdn Life Sciences Investors's stock price today?
HQL last traded at $15.38 as of Nov 20, 4:00 PM EST, down 3.81% on the day. Prices are delayed at least 15 minutes.
Does abrdn Life Sciences Investors pay a dividend?
Yes. abrdn Life Sciences Investors pays $1.91 per share annually, a 12.42% yield. The most recent dividend of $0.62 had an ex-dividend date of Aug 24, 2026.
What is HQL's P/E ratio?
HQL trades at a trailing P/E ratio of 2.32, compared with a median of 7.1 for its closest peers.
What is the HQL 52-week high?
The 52-week high for HQL is $22.67 and the 52-week low is $15.35. The stock is currently 32.2% below its high.